Hungarian Drug Maker Triumphs Over Merck

Law360, New York (February 20, 2007, 12:00 AM EST) -- A Hungarian court has reportedly ruled that the country’s largest drug maker, Richter Gedeon, did not infringe Merck & Co. Inc.’s patent by marketing the osteoporosis drug Sedron.

The Municipal Court in Budapest also said Monday that Richter Gedeon was entitled to damages because it was forced to pull Sedron from the shelves between June 2005 and January 2006.

Though Richter previously estimated the damages of the preliminary injunction at over 3 billion forints ($15.6 million), according to Dow Jones, it did not say how much...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.